On its own, RDW rarely settles a question. Read next to average cell size, hemoglobin and iron markers, it narrows the list of plausible explanations quickly, which is why it appears on almost every blood count printout even though most people have never been told what it is.
RDW measures how much the volume of your red blood cells varies from cell to cell, reported either as a percentage (RDW-CV) or as an absolute volume spread in femtoliters (RDW-SD). It is a measure of inconsistency, not of quantity or quality.
Here is the mechanism. When a blood sample runs through an automated hematology analyzer, the instrument sizes tens of thousands of individual red cells and plots them as a distribution curve. The peak of that curve is the mean corpuscular volume, or MCV, which is the average cell size. The width of the curve is the RDW. A tall narrow curve means your red cells are close to uniform. A short wide curve means you are carrying a noticeably mixed population, some small, some large, some in between.
The clinical word for that mixed population is anisocytosis. Older laboratory reports sometimes described it by eye, as a pathologist looking down a microscope at a blood film and noting that cell size looked variable. The RDW turned that subjective impression into a reproducible number.
A useful way to hold the two apart is to think of a warehouse full of shoes. MCV tells you the average shoe size on the shelves. RDW tells you whether the warehouse stocks mostly one size or everything from a child's size up to the largest adult fitting. Two warehouses can share an identical average and look nothing alike inside.
It matters because red cell size is a record of the conditions in your bone marrow at the moment each cell was made. Red cells circulate for roughly four months before being cleared, so at any given time your bloodstream holds cells built across many different weeks.
If the raw materials and signals stayed steady across that whole window, the cells come out similar and the distribution stays narrow. If something changed partway through, iron stores running down, a vitamin becoming scarce, blood lost and replaced, inflammation altering how the marrow responds, then the newer cohort is built to a different specification than the older one. Both populations circulate side by side, and the distribution widens.
That is the real value of the marker. RDW is less a measurement of a disease than a sensitive detector of recent change. Because a widening spread can appear while hemoglobin and average cell size are still sitting inside their reference ranges, a rising RDW is sometimes the first printed hint that something in red cell production has shifted. It is a prompt to look further, never a conclusion on its own.
Related: Lowering Red Blood Cell Count: What Actually Helps
A typical laboratory reference range for RDW-CV is about 11 to 15 percent, and FitScript's optimal range is narrower.
| Measure | What it reports | Typical lab reference range | FitScript optimal range |
|---|---|---|---|
| RDW-CV | Size spread as a percentage of average red cell volume | 11 to 15 % | 11.5 to 13.5 % |
| RDW-SD | Size spread as an absolute width in femtoliters (fL) | Set by the analyzer and printed on your own report | Not published as a separate target |
These are typical lab reference ranges and they vary by lab, age and sex, so the numbers printed beside your own result are the ones that apply to your sample. FitScript's optimal range is an optimization target, not a diagnostic cut-off, and a value outside it is a reason to look at the rest of the panel rather than a verdict.
Two practical points follow from the table. First, a reference range is built from a reference population, so sitting inside it means you resemble most people tested, not that your iron and vitamin status are ideal. Second, the gap between the standard upper limit and a tighter optimization target is exactly where early, correctable nutritional shifts tend to hide. That is the window worth watching rather than ignoring.
RDW-CV expresses the spread relative to the average cell size, while RDW-SD expresses the spread as an absolute measurement independent of the average. They describe the same underlying variation using different mathematics, which is why they do not always move together.
| Feature | RDW-CV | RDW-SD |
|---|---|---|
| Unit | Percent | Femtoliters (fL) |
| Relationship to MCV | Influenced by average cell size, because the spread is divided by it | Independent of average cell size |
| Behaviour when cells are small | Can read higher, since the same absolute spread is a bigger fraction of a smaller average | Unchanged by the smaller average alone |
| Reported by default | Most commonly reported on routine blood counts | Reported by some analyzers and laboratories only |
The practical consequence is that RDW-CV can drift upward simply because average cell size has fallen, even when the true width of the distribution has not changed much. RDW-SD avoids that distortion and is sometimes the more faithful description of a genuinely mixed population.
If your report lists only one of the two, that is normal. Most routine panels report RDW-CV, and that is the figure the reference range beside it refers to.
An RDW above the reference range means your red cells are more variable in size than expected, and the most common explanations involve nutrition, blood loss, or a change in how fast cells are being produced.
Patterns often considered include early or established iron deficiency, where newly made cells are smaller than the ones already circulating. Vitamin B12 or folate shortfalls work in the opposite direction, producing larger immature cells alongside older normal ones. A mixed deficiency, for example low iron and low B12 together, can widen the distribution dramatically while leaving average cell size deceptively normal.
Blood loss and recovery also widen the spread. After bleeding, heavy menstrual periods or a blood donation, the marrow releases young cells in a burst, and young red cells are larger. The same happens in the first weeks after starting treatment for a deficiency, where a rising RDW can actually be a sign the marrow has started responding. Faster red cell destruction, chronic inflammation, kidney or liver disease, thyroid changes, a recent transfusion mixing two donors' populations, and some inherited hemoglobin variants can all shift the number too.
That is the observation and the range of possible meanings. The next step is not self-diagnosis, it is pairing the result with iron studies, B12, folate and the rest of the blood count, and taking the whole picture to a clinician who can interpret it against your history.
A low RDW generally means your red cells are unusually uniform in size, and in routine practice it is not treated as a problem. Most laboratories flag only the upper limit, and many reports do not define a meaningful lower bound at all.
Uniformity is what a steady, well-supplied marrow produces. A narrow distribution alongside normal hemoglobin and normal average cell size is an unremarkable finding. The more important point is the opposite one, that a normal or low RDW does not rule out a problem. Thalassemia trait classically produces small red cells with a relatively narrow spread, because the cells are uniformly small rather than mixed. Anemia of chronic disease can behave similarly. Someone with a long-standing, stable deficiency may also have replaced most of their circulating cells with the same altered type, narrowing the curve again.
So a tidy RDW is reassuring about consistency, not about adequacy. If hemoglobin is low, if average cell size sits outside its range, or if you have symptoms, a normal RDW is not a reason to stop investigating.
RDW earns most of its clinical keep when it is read beside MCV, because the two together sort low hemoglobin into far fewer plausible categories than either does alone.
| Average cell size (MCV) | Size spread (RDW) | Patterns clinicians often consider |
|---|---|---|
| Low | Normal | Thalassemia trait, some presentations of anemia of chronic disease |
| Low | High | Iron deficiency, mixed nutritional deficiency, some hemoglobin variants, fragmentation of cells |
| Normal | Normal | Normal result, acute blood loss before the marrow responds, anemia of chronic disease |
| Normal | High | Early iron, B12 or folate deficiency, two deficiencies offsetting each other, recent transfusion, early marrow disorders |
| High | Normal | Alcohol intake, liver disease, thyroid underactivity, certain medications, some marrow conditions |
| High | High | B12 or folate deficiency, faster red cell destruction with a young cell response, some marrow disorders |
This grid is a teaching aid, not a diagnostic algorithm, and every row contains more than one explanation on purpose. Confirmation always comes from targeted follow-up testing and clinical assessment, not from the grid itself.
The row that reads normal MCV with high RDW is the one worth understanding. Average cell size can look perfectly ordinary when small iron-poor cells and large B12-poor cells are both present, because the average lands in the middle. The widened RDW is what reveals that the average is hiding two populations.
Research consistently finds that higher RDW is associated with worse outcomes across a wide range of illnesses, although these are group-level statistical associations rather than predictions about any individual.[1] A mini review of RDW as a prognostic marker describes how the association has been reported across many systemic diseases rather than being specific to any one of them[1].
In cardiology, one study of patients hospitalized with heart failure found that both the initial RDW and the change in RDW during the hospital stay were associated with length of stay and 30-day outcomes[2]. In metabolic disease, an analysis of national survey data reported that RDW and the RDW-to-albumin ratio were associated with long-term mortality among people with diabetic neuropathy[3]. During the COVID-19 pandemic, investigators examined the diagnostic accuracy of RDW for predicting death in infected patients[4], and in neonatal medicine researchers assessed RDW alongside procalcitonin for diagnostic and prognostic value in premature infants with septicemia[5].
It also appears in oncology research.[6][7] One study examined how RDW changes relate to established prognostic predictors in newly diagnosed multiple myeloma[6], while another reported that preoperatively elevated RDW-SD and RDW-CV predicted favorable survival in intrahepatic cholangiocarcinoma patients after curative resection[7], a reminder that the direction of the association is not identical in every setting.
Two cautions matter when reading this literature. Most of it looks at people who are already acutely or seriously ill, so it does not translate directly to a healthy adult with a slightly raised number on a routine panel. And a marker that tracks with outcomes is not automatically a cause of them. RDW most likely behaves as a general sensor of physiological disturbance, which is useful information and still not a diagnosis.
Plenty of ordinary circumstances nudge RDW without any underlying disease, which is why context matters before anyone reads meaning into a single figure.
Diet is the obvious one. Low dietary iron, restricted or plant-only eating patterns without attention to B12, and poor absorption from gut conditions or long-term acid suppression can all widen the distribution over months. So can anything that causes slow blood loss, including heavy periods and regular blood donation.
Physiological states count too. Pregnancy increases demand for iron and folate. Living or training at altitude changes red cell production. Heavy endurance training can increase both plasma volume and red cell turnover. Recent transfusion mixes populations by definition. Alcohol intake and liver disease tend to enlarge cells. Thyroid and kidney function both influence red cell production, and some medications affect the marrow or nutrient absorption as a side effect, which is a conversation for the prescriber rather than a reason to stop anything.
Finally there is the laboratory itself. Different analyzers calculate the distribution slightly differently, reference ranges differ between labs, and a sample sitting too long before analysis can shift red cell indices. Comparing a result from one lab against a range printed by another is a common source of unnecessary alarm.
RDW is calculated automatically as part of a complete blood count, from a venous sample drawn into a tube containing EDTA anticoagulant, and the blood count itself does not require fasting.
No separate test is ordered for it. The analyzer derives RDW, MCV, hemoglobin, hematocrit and the rest of the red cell indices from the same run, which is why the marker is effectively free information whenever a blood count is performed. If your appointment also includes glucose, insulin or a lipid panel, the fasting instruction belongs to those tests, not to the blood count.
A few practical points improve reliability. Marked dehydration concentrates the sample and can shift the related red cell numbers, so arriving reasonably hydrated helps. Timing matters if you have recently donated blood, had surgery, been transfused or started an iron or B12 supplement, because all of those change the picture temporarily and the result should be interpreted with that history in view. And because RDW responds to the preceding months rather than the preceding hours, there is no short-term preparation that meaningfully changes the number. What you can do is keep conditions consistent between tests, same lab where possible, similar time of day, so that a trend reflects your biology rather than your logistics.
RDW is close to uninterpretable in isolation, so the markers that give it meaning are the rest of the red cell panel plus the nutrients and signals that drive red cell production.
The immediate companions are hemoglobin and hematocrit, which show whether oxygen-carrying capacity is affected at all, and MCV and MCH, which describe average size and average hemoglobin content per cell. MCH has its own page if you want to see how that average is read in more detail. MCHC, the hemoglobin concentration inside each cell, is the related index that completes the set. Iron status needs more than one marker, typically ferritin alongside serum iron, transferrin or total iron binding capacity, and transferrin saturation, because ferritin also rises with inflammation and can mask depleted stores. If ferritin comes back low, our guide on how to increase ferritin levels walks through food, absorption and retesting. Vitamin B12 and folate complete the nutritional picture, and in some cases a clinician will add further testing when B12 results sit in a grey zone.
Beyond that, a reticulocyte count shows how briskly the marrow is producing new cells, an inflammatory marker such as CRP helps explain a ferritin that looks higher than expected, albumin appears in the RDW-to-albumin ratio[3], and thyroid and kidney function tests cover two systems that quietly influence red cell production. FitScript's membership tests 150+ biomarkers per year, which is the context in which a marker like RDW becomes useful, read as a trend against the nutritional and inflammatory markers that explain it rather than as a lone flagged value.
Read it as one observation, place it beside the rest of the panel, then decide what is worth asking about, in that order.
Start with the observation itself. Note the number, the unit, whether it is CV or SD, and the reference range printed by that specific laboratory. Then look immediately at hemoglobin and MCV. If hemoglobin is normal, average cell size is normal and RDW is slightly above range, that is a mild finding that usually warrants iron and vitamin follow-up rather than concern. If hemoglobin is low as well, the combination carries more weight and deserves a prompt conversation.
Next, consider what may reasonably explain it. Recent donation, heavy periods, pregnancy, a restrictive diet, a recent illness, a new medication or a transfusion all belong in that explanation before anything rarer does.
Finally, look at direction over time. One value is a snapshot. Three values across a year tell you whether the spread is stable, widening or settling back, and that trajectory is far more informative than any single reading. Interpretation written from your own biology, as Atlas produces for members, works the same way, by setting the marker against your history and your other results rather than against a universal threshold.
The useful response is to find out why, because RDW is a signal rather than a target, and treating the number without identifying the cause achieves nothing.
Where a nutritional shortfall is confirmed by testing, food is the sensible foundation. Iron-rich foods include red meat, poultry, shellfish, legumes, tofu and fortified grains, and vitamin C alongside plant sources improves absorption while tea and coffee taken with the meal reduce it. B12 is found in meat, fish, eggs and dairy, and people eating entirely plant-based diets generally need a reliable fortified or supplemental source. Folate comes from leafy greens, legumes and fortified grains. If slow blood loss is the driver, correcting the source matters far more than anything on the plate.
Supplementation is not automatically the answer. Iron taken without confirmed deficiency can cause harm, and vitamin B12 results sometimes need more than one test to interpret. Prescription options for confirmed deficiency, including intravenous iron and injectable B12, exist and work well for the right person, and a licensed provider evaluates whether any of them is appropriate after reviewing your labs and history. This article is educational and is not medical advice. Treatment decisions are for that provider.
A raised RDW becomes a prompt conversation rather than a routine one when it appears alongside low hemoglobin or symptoms, rather than sitting alone on an otherwise unremarkable panel.
Symptoms worth raising promptly include unusual breathlessness on effort, persistent fatigue that rest does not touch, chest pain or palpitations, dizziness or fainting, noticeably pale skin, visible blood in the stool or black tarry stools, blood in vomit, periods heavy enough to disrupt daily life, unexplained weight loss, or new numbness and tingling in the hands and feet, which can accompany B12 problems. A markedly suboptimal result in someone who is pregnant, recovering from surgery, living with heart or kidney disease, or being treated for cancer also deserves earlier review.
What is never the right response is ignoring an abnormal result, deciding it must be a laboratory error, or self-treating with supplements to make the number move. Take the full printout to a clinician or licensed provider and discuss your results and any treatment with them, including your medications, your diet and anything that has changed recently. They have the clinical picture that the number alone cannot supply.
Recheck timing depends on why it was abnormal, and in most cases the answer is measured in weeks to months rather than days, because red cells turn over slowly.
If a deficiency has been identified and addressed, red cell indices need time to reflect the change, since the existing population has to be replaced gradually. Clinicians commonly reassess after a period long enough for new cells to dominate the circulation, and your provider will set the interval based on the cause and the treatment. Repeating a blood count a few days after a single reading rarely tells you anything new, and chasing small week-to-week fluctuations tends to create anxiety rather than insight.
For general health tracking without a specific abnormality, periodic retesting as part of a broader panel is enough, and the value lies in the trend line. A stable RDW across repeated panels is reassuring. A steady upward drift, even inside the reference range, is the kind of early signal that justifies a closer look at iron, B12, folate and inflammation before hemoglobin ever falls. That is the practical argument for regular testing, catching slow movement while it is still easy to explain and easy to correct.
If you want to go deeper on the individual markers discussed here, see the dedicated biomarker pages for RDW, MCV, hemoglobin, ferritin and vitamin B12, and the FitScript Essential panel page for what a baseline blood draw covers.
RDW is red cell distribution width, a routine part of the complete blood count. It describes how much your red blood cells differ from each other in size. A wider spread suggests your circulation holds cells built under different conditions, which can point toward nutritional, blood loss or inflammatory causes worth investigating alongside your other results.
On a blood test report, RDW is the line showing red cell size variation, usually as a percentage with a reference range beside it. It sits near MCV, hemoglobin and hematocrit because those numbers are read together. Alone it identifies nothing, but combined with them it narrows the likely explanations considerably.
It is not a separate test you order. RDW is calculated automatically whenever a complete blood count is run, from the same venous sample. The analyzer sizes thousands of red cells and reports the width of that size distribution, giving clinicians a sensitive early signal that red cell production has recently changed.
Blood test RDW is a measure of red cell uniformity. Low variation means your cells are consistently sized, higher variation means small and large cells are circulating together. Because it can widen before hemoglobin falls, it often flags early iron, B12 or folate shortfalls that deserve follow-up testing with a clinician.
RDW-CV is the coefficient of variation version, reporting size spread as a percentage of average red cell volume. It is the figure most laboratories print by default. Because the calculation divides by average cell size, RDW-CV can read higher when cells are small, even if the absolute spread has not changed much.
RDW-SD is the standard deviation version, reporting size spread as an absolute width in femtoliters rather than a percentage. Unlike RDW-CV, it is not influenced by average cell size, so some laboratories and researchers consider it a more faithful description of a genuinely mixed red cell population. Not every analyzer reports it.
Yes, and that combination is fairly common. Red cell size variation can widen weeks or months before oxygen-carrying capacity falls, so a raised RDW with normal hemoglobin may reflect an early nutritional shift. It is a reason to check iron studies, B12 and folate, not a reason to assume anemia.
No. A raised RDW only means red cell sizes vary more than expected. Recent blood donation, heavy periods, pregnancy, a recent transfusion, alcohol intake, liver or thyroid changes and recovery from a deficiency can all widen it. Interpretation always depends on hemoglobin, average cell size and your clinical history together.